Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE1329.2022.7 (+1.74 %)

PREV CLOSE ( ) 1306.50

OPEN PRICE ( ) 1308.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1731

TODAY'S LOW / HIGH ( )1299.15 1349.00

52 WK LOW / HIGH ( ) 815.81410

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

410.47

368.93

412.16

325.36

Total Expenditure

301.9

280.72

297.9

232.47

PBIDT (Excl OI)

108.57

88.21

114.26

92.89

Other Income

18.8

15.82

18.53

14.06

Operating Profit

127.37

104.03

132.79

106.94

Interest

1.11

1.1

1.16

1.15

Exceptional Items

PBDT

126.26

102.93

131.63

105.79

Depreciation

7.91

7.79

6.39

5.19

Profit Before Tax

118.35

95.14

125.24

100.6

Tax

32.99

30.06

29.22

26.45

Provisions and contingencies

Profit After Tax

85.36

65.08

96.02

74.15

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

85.36

65.08

96.02

74.15

Equity Capital

44.13

Face Value (IN RS)

Reserves

Calculated EPS

19.34

14.74

21.75

16.80

Calculated EPS (Annualised)

77.37

58.98

87.03

67.21

No of Public Share Holdings

2353210

2352850

2351940

2351850

% of Public Share Holdings

53.32

53.31

53.29

PBIDTM% (Excl OI)

26.45

23.90

27.72

28.54

PBIDTM%

31.03

28.19

32.21

32.86

PBDTM%

30.75

27.89

31.93

32.51

PBTM%

28.83

25.78

30.38

30.91

PATM%

20.79

17.64

23.29

22.79

Notes

Risk Disclosures on Derivatives

Quarterly Results

JENBURKT PHARMACEUTICALS LTD.